(F) Ford Motor - Overview
Stock: Trucks, SUVs, Vans, Cars, Luxury Vehicles
| Risk 5d forecast | |
|---|---|
| Volatility | 39.9% |
| Relative Tail Risk | -8.28% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.90 |
| Alpha | 14.70 |
| Character TTM | |
|---|---|
| Beta | 1.080 |
| Beta Downside | 1.060 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.51% |
| CAGR/Max DD | 0.18 |
EPS (Earnings per Share)
Revenue
Description: F Ford Motor February 26, 2026
Ford Motor Company (NYSE:F) designs, manufactures, and services a broad portfolio that includes Ford trucks, SUVs, commercial vans, passenger cars, and Lincoln luxury models across North America, Europe, and other international markets. The firm operates through four segments-Ford Blue (traditional ICE and hybrid vehicles), Ford Model e (electric vehicles), Ford Pro (commercial-fleet solutions), and Ford Credit (automotive financing and leasing). In addition to vehicle sales, Ford provides parts, accessories, digital services, telematics, and EV-charging solutions, while its financing arm offers retail installment contracts, lease programs, and wholesale dealer loans.
In its most recent FY 2025 results, Ford posted $158 billion in revenue, a 6% year-over-year increase driven largely by a 22% surge in Model e EV deliveries, which now represent roughly 20% of total vehicle volume. Operating margin improved to 7.5% as cost-saving initiatives and higher-margin financing activities lifted profitability. Ford Credit’s loan portfolio reached $71 billion, supporting both dealer inventory financing and consumer leases, while free cash flow stood at $5.2 billion, underscoring solid cash generation amid a tightening credit environment. Key macro drivers include the accelerating shift toward electrification, which the sector expects to add $150 billion in cumulative sales by 2028, and ongoing supply-chain normalization that is easing semiconductor bottlenecks.
For a deeper dive into Ford’s valuation metrics and how they compare within the auto sector, you might find ValueRay’s analysis worth exploring.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: -8.18b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 1.95 > 1.0 |
| NWC/Revenue: 4.59% < 20% (prev 9.52%; Δ -4.93% < -1%) |
| CFO/TA 0.07 > 3% & CFO 21.28b > Net Income -8.18b |
| Net Debt (144.22b) to EBITDA (8.99b): 16.04 < 3 |
| Current Ratio: 1.07 > 1.5 & < 3 |
| Outstanding Shares: last quarter (3.98b) vs 12m ago -1.01% < -2% |
| Gross Margin: 6.39% > 18% (prev 0.08%; Δ 631.0% > 0.5%) |
| Asset Turnover: 65.21% > 50% (prev 64.86%; Δ 0.34% > 0%) |
| Interest Coverage Ratio: 2.36 > 6 (EBITDA TTM 8.99b / Interest Expense TTM 1.27b) |
Altman Z'' 0.58
| A: 0.03 (Total Current Assets 123.49b - Total Current Liabilities 114.89b) / Total Assets 289.16b |
| B: 0.08 (Retained Earnings 22.51b / Total Assets 289.16b) |
| C: 0.01 (EBIT TTM 3.00b / Avg Total Assets 287.18b) |
| D: 0.06 (Book Value of Equity 14.84b / Total Liabilities 253.18b) |
| Altman-Z'' Score: 0.58 = B |
Beneish M -2.86
| DSRI: 0.96 (Receivables 64.53b/66.57b, Revenue 187.27b/184.99b) |
| GMI: 1.31 (GM 6.39% / 8.38%) |
| AQI: 1.03 (AQ_t 0.35 / AQ_t-1 0.34) |
| SGI: 1.01 (Revenue 187.27b / 184.99b) |
| TATA: -0.10 (NI -8.18b - CFO 21.28b) / TA 289.16b) |
| Beneish M-Score: -2.86 (Cap -4..+1) = A |
What is the price of F shares?
Over the past week, the price has changed by -13.77%, over one month by -11.00%, over three months by -6.53% and over the past year by +32.93%.
Is F a buy, sell or hold?
- StrongBuy: 3
- Buy: 2
- Hold: 17
- Sell: 1
- StrongSell: 3
What are the forecasts/targets for the F price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 14.1 | 16.4% |
| Analysts Target Price | 14.1 | 16.4% |
F Fundamental Data Overview March 06, 2026
P/S = 0.2729
P/B = 1.4093
P/EG = 9.5994
Revenue TTM = 187.27b USD
EBIT TTM = 3.00b USD
EBITDA TTM = 8.99b USD
Long Term Debt = 106.03b USD (from longTermDebt, last quarter)
Short Term Debt = 57.87b USD (from shortTermDebt, last quarter)
Debt = 167.57b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 144.22b USD (from netDebt column, last quarter)
Enterprise Value = 195.32b USD (51.11b + Debt 167.57b - CCE 23.36b)
Interest Coverage Ratio = 2.36 (Ebit TTM 3.00b / Interest Expense TTM 1.27b)
EV/FCF = 15.67x (Enterprise Value 195.32b / FCF TTM 12.47b)
FCF Yield = 6.38% (FCF TTM 12.47b / Enterprise Value 195.32b)
FCF Margin = 6.66% (FCF TTM 12.47b / Revenue TTM 187.27b)
Net Margin = -4.37% (Net Income TTM -8.18b / Revenue TTM 187.27b)
Gross Margin = 6.39% ((Revenue TTM 187.27b - Cost of Revenue TTM 175.29b) / Revenue TTM)
Gross Margin QoQ = 3.72% (prev 8.51%)
Tobins Q-Ratio = 0.68 (Enterprise Value 195.32b / Total Assets 289.16b)
Interest Expense / Debt = 0.21% (Interest Expense 348.0m / Debt 167.57b)
Taxrate = 21.0% (US default 21%)
NOPAT = 2.37b (EBIT 3.00b * (1 - 21.00%))
Current Ratio = 1.07 (Total Current Assets 123.49b / Total Current Liabilities 114.89b)
Debt / Equity = 4.66 (Debt 167.57b / totalStockholderEquity, last quarter 35.95b)
Debt / EBITDA = 16.04 (Net Debt 144.22b / EBITDA 8.99b)
Debt / FCF = 11.57 (Net Debt 144.22b / FCF TTM 12.47b)
Total Stockholder Equity = 43.26b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.85% (Net Income -8.18b / Total Assets 289.16b)
RoE = -18.91% (Net Income TTM -8.18b / Total Stockholder Equity 43.26b)
RoCE = 2.01% (EBIT 3.00b / Capital Employed (Equity 43.26b + L.T.Debt 106.03b))
RoIC = 1.17% (NOPAT 2.37b / Invested Capital 202.83b)
WACC = 2.44% (E(51.11b)/V(218.68b) * Re(9.89%) + D(167.57b)/V(218.68b) * Rd(0.21%) * (1-Tc(0.21)))
Discount Rate = 9.89% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.66%
[DCF] Terminal Value 88.43% ; FCFF base≈10.18b ; Y1≈12.55b ; Y5≈21.38b
[DCF] Fair Price = 122.1 (EV 622.52b - Net Debt 144.22b = Equity 478.31b / Shares 3.92b; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -50.25 | EPS CAGR: -24.88% | SUE: 0.13 | # QB: 0
Revenue Correlation: 74.48 | Revenue CAGR: 7.92% | SUE: 4.0 | # QB: 7
EPS next Quarter (2026-06-30): EPS=0.39 | Chg7d=-0.012 | Chg30d=-0.029 | Revisions Net=-2 | Analysts=14
EPS current Year (2026-12-31): EPS=1.53 | Chg7d=-0.003 | Chg30d=-0.021 | Revisions Net=+5 | Growth EPS=+40.0% | Growth Revenue=+0.5%
EPS next Year (2027-12-31): EPS=1.84 | Chg7d=+0.017 | Chg30d=+0.024 | Revisions Net=+5 | Growth EPS=+20.4% | Growth Revenue=+1.2%
[Analyst] Revisions Ratio: -0.33 (2 Up / 4 Down within 30d for Next Quarter)